Glooko offers a comprehensive connected care platform designed to improve health outcomes for individuals with diabetes and related chronic conditions. The platform facilitates remote patient management, allowing healthcare providers to monitor and analyze diabetes data collected from patients through various devices, including insulin pumps and continuous glucose monitors (CGMs). Glooko's integration capabilities with electronic health record (EHR) systems streamline workflows, enabling providers to access patient data efficiently and enhance care delivery. The platform also employs predictive algorithms to identify at-risk patients, facilitating timely interventions and improving overall patient management.

In addition to its robust data management features, Glooko emphasizes the importance of security and compliance, ensuring that personal health data is protected. The company has received certifications from key organizations, reflecting its commitment to exceeding data security and quality standards. Glooko's mobile app empowers patients to track their diabetes data, log meals and activities, and access educational resources, fostering collaboration between patients and healthcare providers. This holistic approach not only enhances patient engagement but also supports better clinical outcomes, as evidenced by significant reductions in blood glucose levels and hyperglycemic events reported within three months of using the platform.

United States

Glooko improves health outcomes of people with chronic conditions through its personalized, intelligent, connected care platforms. Our proven technologies make lives better by revolutionizing the connection between patients and providers, driving patient engagement and adherence via digital therapeutics, and accelerating the speed of clinical trials. Glooko is globally deployed in over 30 countries and 8,000+ clinical locations.

Glooko

Company Details